Fmr LLC Viridian Therapeutics, Inc.\De Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Fmr LLC holds 12,238,803 shares of VRDN stock, worth $258 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,238,803

Previous 12,222,986 0.13%

Holding current value

$258 Million

Previous $165 Million 3.84%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$11.02 - $16.09 $174,303 - $254,495	15,817 Added 0.13%	12,238,803 $171 Million
Q1 2025 May 12, 2025	BUY	$13.48 - $20.91 $4.6 Million - $7.13 Million	341,074 Added 2.87%	12,222,986 $165 Million
Q4 2024 Feb 13, 2025	BUY	$17.85 - $25.71 $12.5 Million - $18 Million	698,434 Added 6.25%	11,881,912 $228 Million
Q3 2024 Nov 13, 2024	BUY	$12.16 - $23.33 $19.6 Million - $37.6 Million	1,610,130 Added 16.82%	11,183,478 $254 Million
Q2 2024 Aug 13, 2024	BUY	$11.6 - $17.26 $1.84 Million - $2.73 Million	158,213 Added 1.68%	9,573,348 $125 Million
Q1 2024 May 13, 2024	BUY	$17.09 - $23.82 $30.6 Million - $42.6 Million	1,789,593 Added 23.47%	9,415,135 $165 Million
Q4 2023 Feb 13, 2024	BUY	$11.12 - $22.5 $81.9 Million - $166 Million	7,363,354 Added 2808.43%	7,625,542 $166 Million
Q3 2023 Nov 13, 2023	BUY	$15.16 - $24.7 $6,503 - $10,596	429 Added 0.16%	262,188 $4.02 Million
Q2 2023 Aug 11, 2023	BUY	$22.57 - $29.67 $2.65 Million - $3.49 Million	117,611 Added 81.59%	261,759 $6.23 Million
Q1 2023 May 11, 2023	BUY	$25.04 - $37.6 $3.58 Million - $5.37 Million	142,950 Added 11932.39%	144,148 $3.67 Million
Q4 2022 Feb 13, 2023	BUY	$18.78 - $29.74 $14,178 - $22,453	755 Added 170.43%	1,198 $34,000
Q3 2022 Nov 10, 2022	BUY	$10.7 - $25.5 $4,001 - $9,537	374 Added 542.03%	443 $9,000
Q2 2022 Aug 12, 2022	BUY	$9.55 - $19.0 $658 - $1,311	69 New	69 $1,000

Others Institutions Holding VRDN

# of Institutions

184

Shares Held

82.7M

Call Options Held

78.9K

Put Options Held

417K

View Full List

About Viridian Therapeutics, Inc.\DE

Ticker VRDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,888,900
Market Cap $842M
Description
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...

More about VRDN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account